Your session is about to expire
← Back to Search
Chemotherapy Combination for Leukemia
Study Summary
This trial is testing a combination of drugs to treat patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome. The drugs work in different ways to stop the growth of cancer cells.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor currently recruiting volunteers?
"Per the information available on clinicaltrials.gov, this investigation is actively searching for participants. This research trial was originally advertised on April 4th 2007 and recently updated on July 26th 2022."
Are there analogous investigations into the properties of Fludarabine Phosphate?
"At present, there are 764 trials researching Fludarabine Phosphate with 106 of them in the late-stage phase 3. Grand Rapids, Michigan is where a majority of these studies have been run; however, 16092 clinical sites across the world are running investigations into this medication's efficacy."
How many participants have enrolled for this medical experiment?
"Affirmative. Clinicaltrials.gov data suggests that this clinical trial is open for enrollment and needs 200 people to join at 1 location, as it was first posted on April 4th 2007 and last updated July 26th 2022."
To what ailment is Fludarabine Phosphate usually prescribed?
"Fludarabine Phosphate can be beneficially applied to the treatment of meningeal leukemia, mobilization of hematopoietic stem cells therapy, and acute myelocytic leukemia."
Is Fludarabine Phosphate deemed medically safe for use by patients?
"We at Power assigned Fludarabine Phosphate a score of 2 on the safety scale as it is currently in Phase 2 trials. This implies that there are some data regarding its safety but not with regards to efficacy yet."
Share this study with friends
Copy Link
Messenger